AI-assisted models achieve high accuracy in medical device risk classification, indicating potential for regulatory improvements.
Accurate classification of medical device risk levels is essential for regulatory oversight and clinical safety. Manual classification is labour-intensive and prone to inconsistency, creating bottlenecks in regulatory processes. To address this, we introduce a Transformer-based multimodal framework trained on a real-world corpus of 1,005 Chinese NMPA-registered devices with paired narratives and product images. Our model integrates textual and visual modalities through a cross-attention mechanism and employs a confidence-based self-training loop to enhance generalization under limited supervision. Under 5-fold stratified cross-validation, the best multimodal configuration (SVM with self-training) achieves 91.6% accuracy, 98.86% AUROC, and 87.5% F1, substantially outperforming unimodal baselines (78.4% accuracy text-only; 51.5% accuracy image-only). Ablation studies confirm the complementary benefits of cross-modal attention and robustness analyses show that text-only predictions remain competitive when images are unavailable. Beyond technical gains, we highlight applications in AI-assisted regulatory triage, compliance verification, and support for UDI and GMDN-based device matching within the NMPA context. While validated on Chinese regulatory data, the framework is not assumed to generalize to FDA or EMA contexts without jurisdiction-specific retraining and validation. Our findings suggest that domain-adapted multimodal models, when designed with transparency and calibration, can serve as supporting tools for pre-compliance triage within the originating regulatory jurisdiction.
No takes yet. Share an insight, caveat, or question.
Han et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: